JBIO FY 2024 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$282,000

Operating Income

-$75M

Net Income

-$70M

EPS (Diluted)

$-85.26

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$71M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$80M

Total Liabilities

$4M

Stockholders' Equity

$76M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$282,000	-$96,000	-193.8%
Operating Income	-$75M	-$81M	+8.4%
Net Income	-$70M	-$76M	+7.8%